Record Information |
---|
Version | 2.0 |
---|
Created at | 2006-08-13 02:23:00 UTC |
---|
Updated at | 2020-11-24 22:21:32 UTC |
---|
NP-MRD ID | NP0001195 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | Beta-Leucine |
---|
Description | Beta-leucine is a metabolite that is in the middle of a controversy over its presence in the human body. While there are reports that claim it as a human metabolite, there are others that deny its existence. Two examples:. Circulating levels of beta-leucine are elevated in the cobalamin-deficient state of pernicious anemia. Levels of leucine, on the other hand, are much lower. It is proposed that leucine 2,3-aminomutase, the cobalamin-dependent enzyme that catalyzes the interconversion of leucine and beta-leucine, is the affected enzyme in pernicious anemia and causes these results by preventing the synthesis of leucine from beta-leucine. The synthesis of leucine by human leukocytes and hair roots and by rat liver extracts has been shown to occur when either branched chain fatty acids or valine metabolites are the substances. The synthesis is dependent upon adenosylcobalamin and is inhibited by intrinsic factor (PMID: 7430116 ). Using forms of beta-leucine and leucine that contain several deuterium atoms in place of several hydrogen atoms as internal standards, techniques have been developed which make it possible to detect and quantitate as little as 0.1 Mumol/liter of beta-leucine or leucine in human serum and in incubations containing rat liver supernatant. Beta-Leucine was not detectable, i.E. Less than 0.1 Mumol/liter, in any sera from 50 normal human subjects or in any sera from 50 cobalamin-deficient patients. Experiments in which beta-leucine, leucine, isostearic acid, or isocaproic acid were incubated with rat liver supernatant in the presence or absence of adenosylcobalamin or cobalamin-binding protein failed to demonstrate the formation of leucine or beta-leucine or their interconversion under any of the conditions studied. We conclude that beta-leucine is not present in human blood and that the existence of leucine 2,3-aminomutase in mammalian tissues remains to be established (PMID 3356699 ). Beta-leucine is found to be associated with cobalamin deficiency, which is an inborn error of metabolism. |
---|
Structure | InChI=1S/C6H13NO2/c1-4(2)5(7)3-6(8)9/h4-5H,3,7H2,1-2H3,(H,8,9)/t5-/m0/s1 |
---|
Synonyms | Value | Source |
---|
(S)-Homo-beta-val | ChEBI | (S)-Homo-b-val | Generator | (S)-Homo-β-val | Generator | b-Leucine | Generator | Β-leucine | Generator | 3-Amino-4-methylpentanoic acid | HMDB | beta-2-Amino-4-methylvaleric acid | HMDB | L-beta-Leucine | HMDB | (3S)-b-Leucine | HMDB | (3S)-Β-leucine | HMDB | beta-Leucine | MeSH |
|
---|
Chemical Formula | C6H13NO2 |
---|
Average Mass | 131.1729 Da |
---|
Monoisotopic Mass | 131.09463 Da |
---|
IUPAC Name | (3S)-3-amino-4-methylpentanoic acid |
---|
Traditional Name | β-leucine |
---|
CAS Registry Number | 5699-54-7 |
---|
SMILES | CC(C)[C@@H](N)CC(O)=O |
---|
InChI Identifier | InChI=1S/C6H13NO2/c1-4(2)5(7)3-6(8)9/h4-5H,3,7H2,1-2H3,(H,8,9)/t5-/m0/s1 |
---|
InChI Key | GLUJNGJDHCTUJY-YFKPBYRVSA-N |
---|
Experimental Spectra |
---|
|
| Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, experimental) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, H2O, experimental) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| Predicted Spectra |
---|
|
| Not Available | Chemical Shift Submissions |
---|
|
| Not Available | Species |
---|
Species of Origin | |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as beta amino acids and derivatives. These are amino acids having a (-NH2) group attached to the beta carbon atom. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Carboxylic acids and derivatives |
---|
Sub Class | Amino acids, peptides, and analogues |
---|
Direct Parent | Beta amino acids and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Beta amino acid or derivatives
- Amino fatty acid
- Branched fatty acid
- Methyl-branched fatty acid
- Fatty acyl
- Fatty acid
- Amino acid
- Carboxylic acid
- Monocarboxylic acid or derivatives
- Amine
- Primary amine
- Organooxygen compound
- Organonitrogen compound
- Hydrocarbon derivative
- Primary aliphatic amine
- Organic oxide
- Carbonyl group
- Organopnictogen compound
- Organic oxygen compound
- Organic nitrogen compound
- Aliphatic acyclic compound
|
---|
Molecular Framework | Aliphatic acyclic compounds |
---|
External Descriptors | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | 0.778 | Not Available |
|
---|
Predicted Properties | |
---|
General References | - Stabler SP, Lindenbaum J, Allen RH: Failure to detect beta-leucine in human blood or leucine 2,3-aminomutase in rat liver using capillary gas chromatography-mass spectrometry. J Biol Chem. 1988 Apr 25;263(12):5581-8. [PubMed:3356699 ]
- Poston JM: Cobalamin-dependent formation of leucine and beta-leucine by rat and human tissue. Changes in pernicious anemia. J Biol Chem. 1980 Nov 10;255(21):10067-72. [PubMed:7430116 ]
- Coffey PE, Drauz KH, Roberts SM, Skidmore J, Smith JA: beta-peptides as catalysts: poly-beta-leucine as a catalyst for the Julia-Colonna asymmetric epoxidation of enones. Chem Commun (Camb). 2001 Nov 21;(22):2330-1. doi: 10.1039/b106368p. [PubMed:12240060 ]
|
---|